The constitutive activation of b-catenin signaling in the mammary basal epithelial cell layer in transgenic K5DNbcat mice leads to basal-type tumor development. Integrins of the b1 family and integrin-mediated signaling events have an important role in breast tumor growth and progression. We show here that the deletion of a3b1 integrin, a major laminin receptor, from the basal layer of the mammary epithelium of K5DNbcat mice completely prevented the tumorigenesis induced by b-catenin signaling. Moreover, the depletion of a3b1 integrin from a spontaneously transformed mouse mammary basal epithelial cell line (MEC) prevented the cells from forming colonies in soft agar and greatly reduced tumor development in orthotopic grafts. Inhibition of the integrin signaling intermediates Rac1 or PAK1 (P21-activated Kinase 1) in MEC affected tumor cell growth in soft agar, whereas the expression of activated forms of these effectors in a3-depleted cells rescued the capacity of these cells to grow in non-adherent conditions. Similarly, the tumorigenic potential of a3-depleted cells was restored by the expression of activated PAK1, as assessed by orthotopic transplantation assay. In three-dimensional Matrigel culture, MEC survival and proliferation were affected by the depletion of a3b1 integrin, which also significantly decreased the activation of focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK) and c-Jun NH2-terminal kinase (JNK). Our data suggest that the activation of signaling cascades downstream from a3b1 and involving the Rac1/PAK1 pathway, MAPK and JNK, promotes prosurvival and proproliferative signals required for the malignant growth of basal mammary epithelial cells, providing further insight into the molecular mechanisms underlying breast cancer initiation and progression.
INTRODUCTION
Breast cancers display high levels of cellular and molecular heterogeneity, which influences their responsiveness to treatment. 1 Breast tumors have been classified into four major molecular subtypes on the basis of their expression profiles, and each of these subtypes may be considered as a separate disease. [2] [3] [4] [5] One of these subtypes, basal-like mammary carcinoma, accounts for about 15-20% of breast cancers and is characterized by a poor clinical outcome. Basal-like tumors neither express estrogen and progesterone receptors nor display HER2 overexpression. For this reason, they are often referred to as 'triple-negative' tumors. Basal-like tumors contain cells expressing mammary basal cell markers, such as basal keratins 5 (K5), 14 and 17, and HER1. They also frequently display inactivating p53 mutations and activation of the Wnt/b-catenin pathway. [2] [3] [4] 6, 7 Integrins are ab heterodimeric cell surface adhesion receptors that connect the extracellular matrix to the cytoskeleton, and the binding of extracellular matrix ligands to integrins leads to the activation of adhesion-dependent intracellular signaling pathways. 8, 9 Integrin-mediated adhesion can trigger the activation of numerous signaling intermediates, such as focal adhesion kinase (FAK), Src, the Rho-family GTPases, integrinlinked kinase (ILK), phosphatidylinositol-3 kinase, c-Jun NH2-terminal kinase (JNK) and mitogen-activated protein kinase (MAPK). 9, 10 Moreover, integrins have been reported to be involved in various types of cross-talk with growth factor receptor-mediated signaling. 11 Integrin and associated intracellular signaling effector expression levels and/or activity are often modified during tumor development, suggesting that the adhesion machinery has a role in malignant transformation and tumor progression. 10, [12] [13] [14] Indeed, high levels of b1 integrins correlate with lower survival rates in patients with invasive breast cancer, 15, 16 whereas a3b1 expression in breast carcinoma is associated with metastasis. 17 Moreover, human breast cancers frequently overexpress FAK, 18 and studies in mouse models of breast cancers have provided evidence for a direct role of integrins and associated effectors, such as FAK, Src, ILK and p130Cas, in tumor initiation and development. 10, 19, 20 For example, the deletion of b1 integrins leads to impaired tumor initiation in the MMTV (mouse mammary tumor virus)-PyMT mouse mammary tumor model and reduces metastasis of HER2-driven mouse mammary tumors. 14 Similarly, the deletion of FAK leads to impaired tumor initiation, maintenance and progression in MMTV-PyMT mice. 14, 19, 21 A recent study has implicated b5 integrin in the control of tumorigenic potential of human triple-negative breast cancer cell line.
Integrin a3b1, which binds essentially to laminins 332 and 511, is one of the principal integrins expressed by basal mammary epithelial cells. 10, 23 We recently showed that integrin a3b1 has a major role in controlling the basal epithelial cell contractility required for milk expulsion during lactation, despite being dispensable for mammary gland morphogenesis and differentiation. 24 In addition, data obtained with cultured breast cancer cells suggest that integrin a3b1 may be involved in multiple aspects of tumorigenesis. [25] [26] [27] We investigated the role of a3b1 integrin in tumor development, by assessing the effect of itga3 deletion from basal epithelial mammary cells on mammary tumorigenesis, in a mouse model of breast cancer developed in our laboratory: K5DNbcat transgenic mice. 28 In K5DNbcat mice, the activation of b-catenin signaling in mammary basal epithelial cells leads to the development of mammary lesions resembling human mammary basal-like carcinomas. 28, 29 We show here that the loss of integrin a3b1 from mammary basal cells in K5DNbcat mice prevents the initiation of tumors and that the deletion of the gene encoding a3 integrin chain significantly decreases tumor formation by a mouse mammary basal cell line following its injection into the mammary fat pads of immunodeficient mice. We showed, through in vitro assays, that the loss of a3b1 abolished the ability of basal mammary tumor cells to grow in soft agar and decreased the capacity of these cells to grow in three-dimensional (3D) Matrigel cultures. These effects appeared to be associated with a decrease in the activation of FAK, the Rac1/PAK1 (P21-activated Kinase 1), MAPK and JNK pathways, impeding tumor development. Overall, our data indicate that integrin a3b1-mediated signaling has a critical role in the initiation and/ or growth of mammary tumors.
RESULTS
Targeted disruption of itga3 in the mammary basal epithelial cell layer of K5DNbcat mice prevents tumorigenesis K5DNbcat transgenic mice display constitutive activation of b-catenin signaling in basal mammary epithelial cells. By the age of 10-12 months, they develop mammary lesions, ranging from basal-type mammary hyperplasia to invasive carcinomas ( Figure 1a) . 28, 29 We investigated the potential role of integrin a3b1 in mammary tumorigenesis, by conditionally deleting itga3 from the mammary basal cells of K5DNbcat mice. We have already shown that itga3 deletion in the mammary basal cell layer does not affect mammary development but results in lactation failure because of the impairment of myoepithelial cell contractile activity. 24 The depletion of integrin a3b1 from the mammary basal cell layer of K5DNbcat mice (referred to hereafter as K5a3KO; DNbcat mouse mutants) completely prevented tumorigenesis (Figures 1a-c Table 1 ). Importantly, the small noninvasive lesions found in K5a3KO;DNbcat mice displayed positive staining for a3 integrin, suggesting that they originated from cells that had escaped Cremediated recombination (Supplementary Figure 1) . We reasoned that integrin a3b1 deletion might inhibit tumor initiation in K5DNbcat mice, by interfering with b-catenin transactivation activity. We tested this hypothesis in a mouse mammary myoepithelial cell line, MEC, carrying conditional alleles of itga3. 24 The adenoviral delivery of Cre recombinase, followed by cell sorting with anti-a3 antibody, yielded basal epithelial cells lacking integrin a3b1 (a3KO-MEC; Supplementary Figure 2) .
We compared b-catenin transactivation activity of MEC and a3KO-MEC cells, after transfection with TOPflash/FOPflash reporter plasmids. We found that the stabilized b-catenin mutant activated transcription from the reporter plasmids in a dose-dependent manner in both MEC and a3KO-MEC cells (Figure 1d ). Activation levels appeared to be slightly lower in a3KO-MEC, but the difference in activation between these cells and MEC was not statistically significant, suggesting that integrin a3b1 deletion did not prevent b-catenin-Tcf-driven transcription.
These data indicate that integrin a3b1 controls other steps of mammary tumor initiation and/or growth in K5DNbcat mice than activation of b-catenin per se. These data suggest that integrin a3b1 expression enables mammary tumor cells to proliferate in an anchorageindependent manner, escaping the apoptosis driven by the lack of adhesion.
The capacity of MEC cells to grow in soft agar may result from the activation of a3b1 signaling in tumor cells induced by adhesion-independent mechanisms or by cell-cell adhesion. Indeed, it has been suggested that the a3b1 and a2b1 integrins expressed on the lateral surfaces of epithelial cells may serve for homophilic or heterophilic intercellular interactions. 30 Alternatively (or additionally) a3b1 integrin may be activated in tumor cells growing in soft agar because of the ability of these cells to synthesize and secrete Ln332, the ligand of integrin a3b1. Consistent with this hypothesis, the immunofluorescence labeling of MEC cell colonies in soft agar demonstrated the pericellular deposition of Ln332 (Figure 2e ). We also found Ln332 levels to be high in mammary hyperplasia lesions and moderate in the invasive carcinomas developed in K5DNbcat mice, suggesting a possible role for Ln332 in tumorigenesis (Figure 2f ).
Integrin a3b1-mediated stimulation of the Rac1/PAK1 pathway promotes growth in soft agar and tumor development We have shown that the FAK/Rac1/PAK1 pathway is activated downstream from integrin a3b1, to control myoepithelial cell contractility during lactation. 24 Consistent with this finding, the deletion of itga3 from the mammary basal cell layer in K5DNbcat mice halved the level of FAK phosphorylation (Figures 3a and b) . Moreover, activated/phosphorylated FAK was detected in K5DNbcat mouse mammary tumors, suggesting that FAKmediated signaling had a role in tumor development (Figures 3a and b). We previously showed that Rac1 activity levels were lower in a3KO-MEC than in MEC cells. 24 The expression of a constitutively active form of Rac1 (Rac V12 ) or of a catalytically active form of its effector, PAK1 (PAK CA ), restored the capacity of a3KO-MEC cells to form colonies in soft agar (Figures 3c and d) . Conversely, the treatment of MEC cells with the Rac inhibitor NSC23766, the expression of a dominant-negative form of Rac1 (Rac N17 ) or PAK1 (PAK DN ), or PAK1 silencing by shRNA (PAK-sh) in MEC cells led to an inhibition of colony formation in soft agar, phenocopying a lack of integrin a3b1 (Figures 3c and d and Supplementary Figure 3a) .
Furthermore, the inhibition of PAK1 activity in MEC cells greatly decreased the formation of tumors from cells grafted into the mammary fat pad, whereas the expression of PAK CA in a3KO-MEC cells restored their tumorigenic potential (Figures 3e and f) . Taken together, these results clearly indicate that the Rac1/PAK1 signaling pathway is required downstream from a3b1 integrin to promote tumor development.
The loss of integrin a3b1 results in the impaired activation of FAK, MAPK and JNK, inhibiting MEC proliferation and survival in 3D Matrigel cultures In contrast to their behavior in non-adherent soft agar medium, a3KO-MEC cells developed some spherical colonies when grown in 3D Matrigel cultures. However, a3KO-MEC cells formed far fewer colonies and these colonies were smaller than those formed by control MEC cells (Figures 4a-c) . Colony growth was rescued by 
data not shown). We found that the lower capacity of a3KO-MEC cells to form colonies was associated with higher levels of caspase-3/7 activity at early stages of culture and lower proliferation rates, as demonstrated in a 5-bromo-2 0 -deoxyuridine (BrdU) incorporation assay (Figures 4d and e) . Interestingly, the lack of integrin Figure 3d) . Immunoblots of protein extracts prepared from MEC and a3KO-MEC cells grown in 3D Matrigel revealed that FAK phosphorylation levels were lower in the absence of integrin a3b1 than in its presence (Figures 5c and d) . Taken together, these data indicate that the FAK/Rac1/PAK1 signaling pathway has an essential role downstream from integrin a3b1, in the promotion of colony formation in 3D cultures.
Rac and PAK have been shown to influence the MAP kinase phosphorylation cascade directly, thereby affecting cell proliferation. 31 Immunoblots of the protein extracts obtained from the colonies produced by MEC and a3KO-MEC cells in 3D Matrigel cultures revealed that an absence of integrin a3b1 resulted in Figures 3e and f) . These findings suggest that the activation of integrin a3b1 signaling leads to stimulation of the proproliferative intracellular signaling pathways required for mammary tumorigenesis.
DISCUSSION
In this study, we showed that deletion of the itga3 gene from the mammary epithelial basal layer of K5DNbcat mice prevented the mammary tumorigenesis induced by the activation of b-catenin signaling. Consistent with this observation, cultured mammary basal tumor cells lacking a3b1 were unable to grow in soft agar and were much less able to proliferate in 3D Matrigel cultures or to develop tumors in orthotopic grafts than control cells. Our data suggest that the activation of signaling cascades downstream from a3b1 involving the Rac1/PAK1 pathway, MAPK and JNK promotes the prosurvival and proproliferative signals required for tumorigenesis. Of note, although other integrin dimers are expressed on the surface of mammary epithelial cells, they were unable to substitute for integrin a3b1 to support tumorigenesis. Previously we have shown that deletion of integrin a3b1 from mammary basal cell layer did not perturb adhesion of the mutant mammary epithelium to the basement membrane, suggesting that other integrin dimers ensured adhesion to extracellular matrix. 24 However, it cannot be excluded that, functions of other integrin laminin receptors previously implicated in tumorigenesis, such as a6b1 or a6b4, expressed in mammary epithelial cells, at least, in part, were perturbed by lack of a3b1 and possible subtle abnormalities of the basement membrane underlying a3b1-deficient cells.
Previously, we provided evidence that a3b1-dependent PAK1 activation was required for inhibition of the MLCK (myosin light chain kinase) and subsequent myoepithelial cell relaxation, thereby permitting repetitive contractions during lactation. 24 The findings reported here indicate that MAPK and JNK, similar to Rac1 and PAK1, are intermediates of a3b1 integrin signaling required for tumor development. Thus, integrin a3b1-dependent signal transduction appears to control the activity of several kinases and/ or phosphatases, with effects on biological processes that differ between cell contexts.
The prosurvival and proproliferative effects of MAPK and the FAK/JNK axis are well established, 19, 32, 33 but still little is known about the specific functions of individual integrin dimers in the activation of these intracellular pathways. Previous studies in keratinocytes have implicated integrin a3b1 in FAK/Src and Rac1 activation, leading to polarized lamellipodium extension. 34, 35 In the same cell type, integrin a3b1 has been shown to promote cell survival upon serum withdrawal, through the activation of FAK and MAPK. a3b1 Integrin in basal-like breast cancer S Cagnet et al A pro-oncogenic activity of a3b1 integrin in the highly invasive and metastatic basal-like human breast cancer cell line MDA-MB-231, which presents autocrine Wnt signaling activity has been reported previously. 25, 37 However, in these cells, the overall proliferation and survival were not altered by integrin a3b1 depletion. Instead, a3b1 integrin was found to be required for the tumor cell invasion and the stimulation of angiogenic endothelial cell function in stroma. 25 These data suggest that a3b1 integrin can influence various aspects of tumorigenesis by controlling different cancer cell functions. In addition, it has been recently found that a3b1 integrin can contribute to skin tumor development by promoting epidermal turnover. 38 These results indicate that protumorigenic effects of a3b1 integrin are not restricted to the mammary epithelium.
Whilst in K5DNbcat mice, mammary tumorigenesis is driven by a constitutive activation of b-catenin signaling, MEC line used in this study is a spontaneously immortalized mammary basal cell line and molecular events underlying its tumorigenic properties remain to be defined. One feature common to these two models of mammary tumorigenesis is the origin of the cells targeted for neoplastic conversion. Indeed, in K5a3KO;DNbcat mice, b-catenin gene expression and a3 integrin deletion were targeted to the mammary basal epithelial cell layer, 28 whereas the MEC line is also of mammary basal epithelial origin. 24 Studies from the Nusse laboratory have implicated canonical Wnt signaling in the control of mouse mammary basal stem cell self-renewal. 39 Consistent with these findings, we observed the amplification of basal stem/ progenitor cell populations in early mammary lesions of K5DNbcat mice, suggesting that in this model, mammary basal-like tumors may originate from basal stem/progenitor cells. 28, 29 Amplification of the basal stem/progenitor cell compartment has also been reported in the human mammary epithelium, following activation of the Wnt/b-catenin pathway. 40 We have shown that the loss of b1 integrins from the mammary basal cell layer severely impairs stem cell function. 41 One possible explanation for the inhibition of tumorigenesis in K5DNbcat mice following a3 integrin deletion is, therefore, an impairment of basal stem cell self-renewal, leading to depletion of the stem cell population. Similarly, the lower tumorigenic potential of the MEC line after deletion of the gene encoding integrin a3 may reflect a decrease in the pool of tumor-initiating cells. Deficiencies in the activation of FAK, MAPK and JNK can result in senescence and may compromise survival within the basal stem cell compartment in vivo in K5DNbcat mice and in vitro in the MEC line. Two recent studies have suggested that basal-like Brca1-associated mammary tumors originate from luminal progenitors. 42, 43 Therefore, we are currently analyzing the effects of a3b1 integrin deletion on mammary basal and luminal stem/progenitor cell populations. So far, there is no direct evidence implicating integrin a3b1 in luminal-type breast tumorigenesis. However, in the MMTV-PyMT and ErbB2 mouse models of luminal breast cancer, b1 integrins and several intermediates of integrin signaling, respectively, have been found to have essential roles in various steps of malignant tumor progression. 10, 14, 19 Our work and previously obtained data on the tumorpromoting functions of a3b1 in cultured breast cancer cells suggest that this integrin could be targeted in anticancer therapy. 27 Furthermore, expression of a3b1 integrin appeared to be upregulated in mammary lesions of K5DNbcat mice. 29 Future studies will help to define whether a3b1 integrin can serve as a basal-like human breast cancer marker and to unravel the contribution of this integrin into induction and/or propagation of various types of human breast cancer.
In brief, we show here that integrin a3b1-mediated signaling events are required for the malignant growth of mammary basal epithelial cells, providing further insight into the molecular mechanisms underlying breast cancer initiation and progression.
MATERIALS AND METHODS

Mouse strains
All animal experiments were conducted in accordance with French veterinary guidelines and Council of Europe guidelines for the use of experimental animals (L358-86/609EEC). Mice expressing DN57b-catenin in mammary basal epithelial cells (referred to as the K5DNbcat strain) have been described elsewhere. 28 The K5-Cre mice were kindly provided by Dr J Jorcano. 44 The mice carrying conditional integrin a3 alleles (itga3 F/F ) have been described elsewhere. 45 The mice were killed when at least one palpable tumor was detected, and all glands were examined in wholemount preparations for the presence of hyperplasia or tumors.
Morphological analyses and immunolabeling
Dissected mammary glands were spread onto a glass slide, fixed in MethaCarn and either stained with Carmine alum in whole mount or embedded in paraffin. For cryosectioning, mammary tissue was embedded in cryoprotectant (Tissue-Tek OCT, TissuTek, Samura-FineTek, Torrance, CA, USA). For immunofluorescence labeling, frozen or paraffin-embedded 5-to 7-mm-thick sections were processed as described previously. 28, 46 Cell nuclei were stained with 4 0 ,6-diamidino-2-phenylindole (DAPI). The following primary antibodies were used: mouse monoclonal anti-a-smooth muscle actin (no. 1A4; Sigma-Aldrich, Saint-Quentin Fallavier, France), anti-HA (no. 12CA5; Roche Applied Science, Basel, Switzerland), anti-keratin 8 (no. AF 138; Covance, Princeton, NJ, USA), anti-BrdU (no. 3D4; BD Pharmingen, San Diego, CA, USA) and anti-integrin a3 (no. J143; ab11767; Abcam, Cambridge, MA, USA); rat monoclonal anti-integrin b1 (no. MB1.2, Chemicon-Millipore, Temecula, CA, USA); and rabbit polyclonal antibodies against a3A integrin (no. 141742, described elsewhere 47 ), K5 (no. AF138; Covance) and laminin 332 (no. 1097 þ E kindly provided by T Sasaki, Max-Planck Institute, Munich, Germany). All secondary antibodies and phalloidin were conjugated to Alexafluor fluorochromes (Molecular Probes, Eugene, OR, USA). The photomicrographs shown in Figures 2e and 4e,f were acquired with a Nikon A1r confocal microscope (Nikon Instruments, Tokyo, Japan) and correspond to maximal projections of 36 sections of 1 mm and 45 sections of 0.5 mm, respectively. The other immunofluorescence images were obtained with a Leica DM6000B microscope (Leica Microsystems CMS GmbH, Wetzlar, Germany).
Preparation of mammary basal epithelial cells and quantitative reverse transcription-polymerase chain reaction
The inguinal mammary glands of three to four 25-week-old virgin females were pooled for the preparation of single-cell suspensions and basal cells were processed for flow cytometry, as described elsewhere. 41 The following conjugated antibodies were used: anti-CD24-PE (no. M1/69; BD Pharmingen), anti-CD49f-FITC (no. GoH3; BD Pharmingen), anti-CD45-APC (#30-F11; Biolegend, San Diego, CA, USA) and anti-CD31-APC (no. MEC13.3; Biolegend). Mammary basal epithelial cells were sorted on a FACSVantage flow cytometer (Becton Dickinson, San Jose, CA, USA) and RNA was subsequently isolated with the RNeasy kit (Qiagen Gmbh, Hilden, Germany). Quantitative reverse transcription-polymerase chain reaction was performed as described previously. 48 Values were normalized with respect to glyceraldehyde phosphate dehydrogenase (gapdh) expression levels by the comparative CT method. The primers used for gapdh have been described elsewhere. 48 The other primers were purchased from SABiosciences (Frederick, MD, USA) or Qiagen.
Cell culture assays
The established MEC line of the itga3 F/F genotype 24 was routinely maintained in low-serum medium consisting of Dulbecco's modified Eagle's medium:F12 (Gibco-BRL, Gibco, Invitrogen, Saint Aubin, France) buffered with 15 mM HEPES, pH 7.6 (Sigma-Aldrich) and supplemented with 10 mg/ml insulin (Sigma-Aldrich), 5 ng/ml epidermal growth factor (Sigma-Aldrich), 0.5 mg/ml bovine serum albumin (Sigma-Aldrich), 5 mg/ml linoleic acid complex (Sigma-Aldrich), 2% calf serum (HyClone Laboratories, Logan, UT, USA), 50 mg/ml gentamicin (Sigma-Aldrich) and 20 U/ml nystatin (Sigma-Aldrich). Initially not tumorigenic, with passages, MEC acquired the capacity to give rise to tumors, when injected subcutaneously into nude mice. Cre-mediated deletion of itga3 F/F alleles, retroviral delivery of the human a3A subunit cloned into the pLZRS-MSIRESZeo/pBR vector to a3KO-MEC, flow cytometry and cell sorting with, respectively, BD FACSCalibur and FACSVantage (Becton Dickinson) flow cytometers, were carried out according to previously described protocols. 45, 46 Infected a3KO-MEC cells were maintained under zeocin selection (300 mg/ml; no. ant-zn-5; Invivogen, San Diego, CA, USA For the TOP/FOP luciferase reporter assay, 1.5 Â 10 5 MEC or a3KO-MEC cells were transfected by lipofection (Lipofectamine, Plus Reagent; Invitrogen) kit according to the manufacturer's instructions. A total of 400 ng total DNA, containing 100 ng of reporter plasmid (TOP/FOP) provided by Dr H Clevers (Hubrecht Laboratory, Utrecht, The Netherlands) 49 and 10 ng of pTK-Renilla luciferase control vector (Promega, Madison, WI, USA) were used. When indicated, 100 ng of a plasmid encoding a constitutive active form of TCF or 10-100 ng of a plasmid encoding a stabilized form of b-catenin lacking the NH 2 -terminal 57 amino acids (pCGN-DN57-b-catenin) 50 were added. Thirty-six hours after transfection, the cells were lysed and Firefly and Renilla luciferase activities were measured. The mean ratio of TOP and FOP reporter activity levels (means±s.d.) was determined in four independent experiments with duplicate measurements in each case. Basal activity in MEC cells was arbitrarily set to a value of 1.
For growth in soft agar medium, 5 Â 10 4 cells were plated in medium containing 0.35% low-melting point agarose (Gibco-BRL) in six-well plates coated with 0.6% low-melting point agarose . Colonies with areas of more than 1500 mm 2 were counted after 2 weeks of incubation, with ImageJ software (http://rsb.info.nih.gov/ij). The results shown are representative of at least three independent experiments performed in duplicate.
For 3D cultures of MEC, 6 Â 10 3 cells per well in 24-well Ultra-Low Attachment plates (Costar-Corning, New York, NY, USA) were plated in the presence of 10% Matrigel (BD Pharmingen). ImageJ software was used to count the colonies with areas of more than 1500 mm 2 , after 11 days of incubation. Caspase-3/7 activity was assessed in colonies harvested 24 h after plating, with the Caspase-Glo 3/7 Assay System, according to the manufacturer's instructions (Promega). For BrdU incorporation experiments, colonies were incubated with 5 mg/ml BrdU for 1 h on day 8 after seeding.
For the orthotopic injection of MEC and a3KO-MEC cells into the mammary fat pad of BALB/c nude mice, a suspension of 10 5 cells was prepared in 100 ml of phosphate-buffered saline. Data are shown as means ± s.e.m. for, at least, six injections performed in two independent experiments.
Protein extracts, immunoprecipitation and immunoblotting
Protein extracts were prepared from the fifth mammary glands of females on the first day of lactation, mammary tumors, subconfluent cell cultures and 3D Matrigel colonies harvested on day 8, as described previously. 24 Immunoprecipitation and immunoblotting were performed as described a3b1 Integrin in basal-like breast cancer S Cagnet et al
